Atlas Trials

Study of Aztreonam for Inhalation in Children With Cystic Fibrosis and New Infection of the Airways by Pseudomonas Aeruginosa Bacteria

Clinical trial NCT03219164 · TERMINATED

Trial details

NCT number
NCT03219164
Sponsor
Gilead Sciences
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Pseudomonas Aeruginosa Respiratory Tract Infection/ColonizationCystic Fibrosis
Start date
2017-11-28
Primary completion
2020-05-27
Enrollment
149

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.